DIFESA CAPITAL MANAGEMENT, LP - THE ONCOLOGY INSTITUTE INC ownership

THE ONCOLOGY INSTITUTE INC's ticker is and the CUSIP is 68236X118. A total of 20 filers reported holding THE ONCOLOGY INSTITUTE INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
DIFESA CAPITAL MANAGEMENT, LP ownership history of THE ONCOLOGY INSTITUTE INC
ValueSharesWeighting
Q2 2023$3,724
-66.1%
82,749
-28.6%
0.01%
+42.9%
Q1 2023$10,994
-13.9%
115,9750.0%0.01%
-30.0%
Q4 2022$12,769
-78.4%
115,9750.0%0.01%
-66.7%
Q3 2022$59,000
+1.7%
115,9750.0%0.03%
-9.1%
Q2 2022$58,000
-59.7%
115,975
-7.2%
0.03%
-54.8%
Q1 2022$144,000
+67.4%
125,0000.0%0.07%
+25.9%
Q4 2021$86,000125,0000.06%
Other shareholders
THE ONCOLOGY INSTITUTE INC shareholders Q1 2023
NameSharesValueWeighting ↓
LMR Partners LLP 1,568,564$1,063,3300.02%
DIFESA CAPITAL MANAGEMENT, LP 115,975$10,9940.01%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 1,250,000$81,3750.00%
Alpine Global Management, LLC 25,024$1,5160.00%
COWEN AND COMPANY, LLC 120,300$7,8310.00%
HIGHBRIDGE CAPITAL MANAGEMENT LLC 262,751$250.00%
Man Group plc 94,740$9,3790.00%
Citadel Advisors 17,307$1,6410.00%
BANK OF AMERICA CORP /DE/ 100$60.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of THE ONCOLOGY INSTITUTE INC shareholders